FDA Alerts

The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.

A new treatment for amyotrophic lateral sclerosis, also known as Lou Gehrig disease, was recently approved by the US Food and Drug Administration.

The FDA granted accelerated approval for a new treatment for patients with locally advanced or metastatic urothelial carcinoma.

Due to manufacturing problems in late 2015, supplies of the US-licensed yellow fever vaccine are expected to be completely depleted by the middle of 2017. In a recent report, the CDC detailed its plan to...

The US Food and Drug Administration has approved a new treatment for osteoporosis for postmenopausal women at a high risk for fracture.

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.

The FDA approved the first spirometer specifically developed for wireless home use for the monitoring of asthma, COPD, and other diseases.

The US Food and Drug Administration has approved a new option for the treatment of a specific form of Batten disease in pediatric patients aged 3 years and older.

The FDA has approved the first new option for the treatment of liver cancer, specifically hepatocellular carcinoma, in nearly 10 years.

The first immediate-release opioid to receive abuse-deterrent labeling was recently approved by the FDA.